These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

631 related items for PubMed ID: 22092967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C.
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [Abstract] [Full Text] [Related]

  • 5. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V, Batard T, Nguyen H, Fréreux M, Horiot S, Harwanegg C, Bergmann KC, de Beaumont O, Moingeon P.
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [Abstract] [Full Text] [Related]

  • 6. Proteinase-activated receptor-2 activation participates in allergic sensitization to house dust mite allergens in a murine model.
    Davidson CE, Asaduzzaman M, Arizmendi NG, Polley D, Wu Y, Gordon JR, Hollenberg MD, Cameron L, Vliagoftis H.
    Clin Exp Allergy; 2013 Nov; 43(11):1274-85. PubMed ID: 24152160
    [Abstract] [Full Text] [Related]

  • 7. House Dust Mite-Specific Sublingual Immunotherapy Prevents the Development of Allergic Inflammation in a Mouse Model of Experimental Asthma.
    Hagner S, Rask C, Brimnes J, Andersen PS, Raifer H, Renz H, Garn H.
    Int Arch Allergy Immunol; 2016 Nov; 170(1):22-34. PubMed ID: 27287860
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.
    Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, Van Overtvelt L, Moingeon P.
    J Allergy Clin Immunol; 2007 Aug; 120(2):278-85. PubMed ID: 17531296
    [Abstract] [Full Text] [Related]

  • 11. Increase in allergen-specific IgE and ex vivo Th2 responses after a single bronchial challenge with house dust mite in allergic asthmatics.
    van de Pol MA, Lutter R, van Ree R, van der Zee JS.
    Allergy; 2012 Jan; 67(1):67-73. PubMed ID: 21958117
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L, Wang J, Chen Y, Luo R, Tao J, Nie M, Liu B, Li Y.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [Abstract] [Full Text] [Related]

  • 13. The influence of chitin on the immune response to the house dust mite allergen Blo T 12.
    Zakzuk J, Benedetti I, Fernández-Caldas E, Caraballo L.
    Int Arch Allergy Immunol; 2014 Oct; 163(2):119-29. PubMed ID: 24335274
    [Abstract] [Full Text] [Related]

  • 14. Interferon response factor 3 is essential for house dust mite-induced airway allergy.
    Marichal T, Bedoret D, Mesnil C, Pichavant M, Goriely S, Trottein F, Cataldo D, Goldman M, Lekeux P, Bureau F, Desmet CJ.
    J Allergy Clin Immunol; 2010 Oct; 126(4):836-844.e13. PubMed ID: 20673978
    [Abstract] [Full Text] [Related]

  • 15. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
    Yonekura S, Okamoto Y, Sakurai D, Horiguchi S, Hanazawa T, Nakano A, Kudou F, Nakamaru Y, Honda K, Hoshioka A, Shimojo N, Kohno Y.
    Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
    [Abstract] [Full Text] [Related]

  • 16. Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.
    Mondoulet L, Dioszeghy V, Puteaux E, Ligouis M, Dhelft V, Plaquet C, Dupont C, Benhamou PH.
    J Allergy Clin Immunol; 2015 Jun; 135(6):1546-57.e4. PubMed ID: 25583102
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Co-administration of vaccination with DNA encoding T cell epitope on the Der p and BCG inhibited airway remodeling in a murine model of chronic asthma.
    Kim CH, Ahn JH, Kim SJ, Lee SY, Kim YK, Kim KH, Moon HS, Song JS, Park SH, Kwon SS.
    J Asthma; 2006 Jun; 43(5):345-53. PubMed ID: 16801138
    [Abstract] [Full Text] [Related]

  • 19. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L, Petersen AH, Nawijn MC.
    Methods Mol Biol; 2021 Jun; 2223():295-335. PubMed ID: 33226602
    [Abstract] [Full Text] [Related]

  • 20. Lipopolysaccharide inhibits Th2 lung inflammation induced by house dust mite allergens in mice.
    Daan de Boer J, Roelofs JJ, de Vos AF, de Beer R, Schouten M, Hommes TJ, Hoogendijk AJ, de Boer OJ, Stroo I, van der Zee JS, Veer CV, van der Poll T.
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):382-9. PubMed ID: 23239494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.